BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11713757)

  • 21. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling human hematopoietic stem cell gene therapy in nonhuman primates.
    Hematti P
    Curr Hematol Rep; 2004 Jul; 3(4):282-9. PubMed ID: 15217558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
    Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells.
    Yoshimitsu M; Higuchi K; Ramsubir S; Nonaka T; Rasaiah VI; Siatskas C; Liang SB; Murray GJ; Brady RO; Medin JA
    Gene Ther; 2007 Feb; 14(3):256-65. PubMed ID: 16929352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
    Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotoxicity of retroviral integration in hematopoietic cells.
    Nienhuis AW; Dunbar CE; Sorrentino BP
    Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.
    Siapati EK; Bigger BW; Kashofer K; Themis M; Thrasher AJ; Bonnet D
    Eur J Haematol; 2007 Apr; 78(4):303-13. PubMed ID: 17378892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy clinical trials for HIV.
    Statham S; Morgan RA
    Curr Opin Mol Ther; 1999 Aug; 1(4):430-6. PubMed ID: 11713756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
    Jamieson BD; Aldrovandi GM; Zack JA
    Semin Immunol; 1996 Aug; 8(4):215-21. PubMed ID: 8883144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional targeting of B cells with viral vectors.
    Friedrich RI; Nopora K; Brocker T
    Eur J Cell Biol; 2012 Jan; 91(1):86-96. PubMed ID: 21458103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prospects for gene therapy in hematology].
    Moreau-Gaudry F; Mazurier F; Salesse S; Fontanellas A; Verneuil HD
    Ann Biol Clin (Paris); 1999; 57(1):43-50. PubMed ID: 9920966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current status of gene therapy in autologous transplantation.
    Becker PS
    Acta Haematol; 2005; 114(4):188-97. PubMed ID: 16269858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transduction of hematopoietic stem cells in humans and in nonhuman primates.
    Dunbar CE; Tisdale J; Yu JM; Soma T; Zujewski J; Bodine D; Sellers S; Cowan K; Donahue R; Emmons R
    Stem Cells; 1997; 15 Suppl 1():135-9; discussion 139-40. PubMed ID: 9368333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micro-injection-mediated hematopoietic stem cell gene therapy.
    Davis BR; Brown DB; Prokopishyn NL; Yannariello-Brown J
    Curr Opin Mol Ther; 2000 Aug; 2(4):412-9. PubMed ID: 11249771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks.
    Weber E; Anderson WF; Kasahara N
    Curr Opin Mol Ther; 2001 Oct; 3(5):439-53. PubMed ID: 11699888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of gene therapy in X-linked severe combined immunodeficiency.
    Rans TS; England R
    Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene transfer into hematopoietic stem cells: prospects for human gene therapy.
    Einerhand MP; Valerio D
    Curr Top Microbiol Immunol; 1992; 177():217-35. PubMed ID: 1353431
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene therapy utilizing drug resistance genes: a review.
    Banerjee D; Zhao SC; Li MX; Schweitzer BI; Mineishi S; Bertino JR
    Stem Cells; 1994 Jul; 12(4):378-85. PubMed ID: 7951004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.